Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178.

about

Critical review of non-statin treatments for dyslipoproteinemia.Increased ANGPTL3, 4 and ANGPTL8/betatrophin expression levels in obesity and T2D.

P2860

Q38186099-D72285DF-4C9D-4652-B089-840B35874376 Q39298579-F0057B6E-42BD-4429-8D88-0391A851BFB5

P2860

Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178.

Item

http://www.wikidata.org/entity/Q44239582

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178.

@en

Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178.

@nl

type

Item

label

Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178.

@en

Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178.

@nl

prefLabel

Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178.

@en

Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178.

@nl

P1476

Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178.

@en

P2093

Junji Kobayashi

http://www.w3.org/2001/XMLSchema#string

Katsuyuki Nakajima

http://www.w3.org/2001/XMLSchema#string

P2860

Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase

Biological, clinical and population relevance of 95 loci for blood lipids

Probucol markedly reduces HDL phospholipids and elevated prebeta1-HDL without delayed conversion into alpha-migrating HDL: putative role of angiopoietin-like protein 3 in probucol-induced HDL remodeling

Probucol inhibits ABCA1-mediated cellular lipid efflux

Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia

ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase

Angptl3 regulates lipid metabolism in mice

Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization.

Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo.

An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genes

P304

113-119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543776.2013.842555

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24094083

http://www.w3.org/2001/XMLSchema#string

Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178.

about

P2860

P2860

Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698